Luke M. Beshar
Chief Financial Officer, Cambrex Corporation.
Companies
- Proteon TherapeuticsBoard member Jan 13, 2020 to now1
- Omega Therapeutics, Inc.Board member Jul 29, 2021 to Jun 9, 20232
- Trillium Therapeutics Inc.Board member Jan 4, 2021 to Nov 19, 20213
- REGENXBIO Inc.Board member Sep 16, 2015 to Jun 8, 20214
- NPS Pharmaceuticals (United States)Chief financial officer Nov 20, 2007 to Feb 24, 20155
- Cambrex CorporationExecutive Vice President Jan 30, 2007 to Oct 12, 20076
- Cambrex CorporationChief financial officer Jan 30, 2006 to Jan 25, 20077
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Proteon Therapeutics TARA198,000 shares8$471.2K at $2.38Jun 30, 2022
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 30, 2022Bought 10,000 shares at $3.10 of Proteon Therapeutics8
- Mar 14, 2022Bought 10,000 shares at $4.25 of Proteon Therapeutics9
- Mar 10, 2022Bought 10,000 shares at $4.46 of Proteon Therapeutics10
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARProteon Therapeutics, Board member
- 2
- 3
- 4SEC EDGARREGENXBIO Inc., Board member
- 5
- 6
- 7
- 8
- 9SEC EDGARForm 4 filed Mar 16, 2022
- 10SEC EDGARForm 4 filed Mar 14, 2022